Jump to content

Drug vectorization

From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Kku (talk | contribs) at 17:01, 28 January 2016 (stub). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

In pharmacology and medicine vectorization of drugs refers to intracellular targeting with plastic or silicon nanoparticles or liposomes to which pharmacologically active substances are reversibly bound or attached by adsorption.[1][2]

CNRS researchers have devised a way to overcome the problem of multidrug resistance using polyalkylcyanoacrylate (PACA) nanoparticles as "vectors".[3]

References

  1. ^ Couvreur P. (2001). "Drug vectorization or how to modulate tissular and cellular distribution of biologically active compounds". Ann Pharm Fr. 59 (4): 232–8. PMID 11468577.
  2. ^ {{"Antibody-functionalized porous silicon nanoparticles for vectorization of hydrophobic drugs". Adv Healthc Mater. 2 (5): 718–27. 2013. doi:10.1002/adhm.201200335. PMID 23203914.
  3. ^ http://www.cnrs.fr/Cnrspresse/en380a6.htm

This article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Drug_vectorization&oldid=702129848"